Harvard Medical School Corporate Learning’s Post

Clinical Trial Phases and Study Types - a comprehensive guide Explore the phases and types of clinical trials, from exploratory to confirmatory studies. Understand the nature of each phase and study design for effective research planning. Read more: https://lnkd.in/gb9yK2j3 #ClinicalTrials #StudyTypes #ResearchGuide #MedicalResearch #Healthcare #ClinicalTrialPhases #ClinicalResearch #MedicalStudies #ResearchMethods

McKinsey comments on how to improve clinical trials by overcoming those challenges. - Low R&D productivity driven by lengthy clinical trial timelines and increasing trial costs VS Apply innovative trial designs to reduce total required study participants - Challenges in recruitment for clinical trials VS Differentiate with simpler, patient-centric protocols - Increasing demand for trial participants VS Take a data-and-analytics approach to site selection and management - Rising burden on sites VS Reconsider site experience - Challenging physician incentives VS Reimagine the point of delivery for clinical trials https://lnkd.in/gwB_SHVE

What an inspiring and insightful conversation today about best practices and future opportunities for including the voice of the patient in every step of the #drugdevelopment process. The discussion quickly ran out of time and many of the more than 100+ audience comments unfortunately had to go unaddressed. But, this is just the beginning of the conversation - submit your thoughts and recommendations to the docket using this link https://lnkd.in/dBYZp63A Some of the key take-aways for me included the need to evolve the public discourse on the issue from the theoretical and abstract to tangible recommendations and practical advice; the richness and value that differences in opinion, cultural heritage, and lived experience bring to this important discussion (and make for a very lively debate); and the foundational importance of trust, shared expectations, and clear and effective two-way communication. Our patients do not have time to waste on failed clinical trials and ineffective drug development programs. The best (and often only) way to ensure rare disease drug development programs have the maximum chance of success is to ensure everyone - sponsors, CROs and trial sites, patients and families, regulators, academic researchers, and more - is on the same page and that no program for our patients is developed without meaningful engagement of our patients. Nowadays, nobody would even think to develop a household good or service without meaningful end-user engagement - and rare-disease therapies are infinitely more complex and important to our patients and families. We see that patient experience data is increasingly central to #raredisease drug development and today's workshop certainly reinforced that. Thank you to FDA and the Duke-Margolis Center for Health Policy for including me and the National Organization for Rare Disorders in this important discussion!

For sponsors and CROs, reducing time-to-market and improving patient access to innovative treatments remain pressing challenges and top priorities. That is why they must partner with a central lab with a global presence. Check out our latest blog where we dive into the top 7 considerations when choosing a central lab partner => https://lnkd.in/eczfSX5c #LabConnect #GlobalCentralLab #CentralLab #FSPSolutions

Please see below for how LabConnect can enhance your clinical trials!

Helpful to keep these in mind as you’re choosing a partner for your clinical trial.

Sharing the latest blog from my team at LabConnect! Is your central lab partner delivering across these 7 areas?

#LabConnect #GlobalCentralLab #CentralLab #FSPSolutions For sponsors and CROs, reducing time-to-market and improving patient access to innovative treatments remain pressing challenges and top priorities. That is why they must partner with a central lab with a global presence. Check out our latest blog where we dive into the top 7 considerations when choosing a central lab partner 👉 https://lnkd.in/eczfSX5c

No matter the size or complexity of your clinical trial, LabConnect can help get your samples where they need to be.

Smarter clinical trials can get us where we want to go